CRL
CRL
NYSE · Life Sciences Tools & Services

Charles River Laboratories

S&P 500 Mid-Cap Stocks Healthcare Stocks
$159.19
+1.19 (+0.75%)
As of Mar 24, 9:46 PM ET ·
Analyst Consensus
Buy
23
Analysts
High
Coverage
Buy 14 61%
Hold 9 39%
Sell 0 0%
Price Target
Analyst Price Target -55.3% upside
Low Target $57.45
Average Target $71.21
High Target $105.86
Current Price $159.19
Current
$159.19
Target
$71.21
$57.45 $71.21 avg $105.86
Scenario Analysis
Bear Case
$57.45
-63.9%
Low target
Base Case
$71.21
-55.3%
Avg target
Bull Case
$105.86
+-33.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$228.88
-30.4% from high
52-Week Low
$91.86
+73.3% from low
50-Day SMA
$200.46
-20.6% vs SMA
200-Day SMA
$169.92
-6.3% vs SMA
RSI (14)
21.1
Oversold
Target vs 52W High
$71.21
-68.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 33 88% $369.21 -24.7%
DHR
Danaher Corp
 Strong Buy 30 87% $158.11 -16.8%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -43.4%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -50.1%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -86.5%
ILMN
Illumina Inc
 Hold 28 54% $169.36 +34.4%
WAT
Waters Corp
 Buy 28 57% $189.60 -37.2%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -44.5%